Healthcare Investment in 2006-2016: Error Analysis

January 13, 2017, 09:30 – 11:30, Building 5, 5th Floor, Executive Conference Room

Presentation on the launch of a study of the return on investment in the health care sector of the Russian Federation and generation of proposals for development and investment areas in the Russian health care system. 

Issues for Discussion

  • The definition of investment in the health system of the Russian Federation: what investments yield tangible results and what are the health care areas that will be able to make the best use of investments?
  • How to change the approach to investment in health care: a different perception of investment by health care system participants and legislative changes for better performance and a healthier nation?
  • Private investment for the benefit of the State: how to use private capital for the development of the public health care system. Does a healthier nation mean a better return on the investment?


  • Igor Kagramanyan
    Igor Kagramanyan

    First Deputy Chairman, Committee on Social Policy, Federation Council of the Russian Federation

  • Yulia Mikheeva
    Yulia Mikheeva

    Director, Social Development Department, Ministry of Economic Development of the Russian Federation

  • Adel Vafin
    Adel Vafin

    Minister of Healthcare of the Republic of Tatarstan

  • Vadim Vlasov
    Vadim Vlasov

    President, Novartis Group

  • Zakhar Golant
    Zakhar Golant

    Vice-Rector for Innovation Development, St. Petersburg State Chemical Pharmaceutical Academy

  • Gregory Potapov
    Gregory Potapov

    General Director, Pharmstandart

  • Jane Griffiths
    Jane Griffiths

    Company Group Chairman, Janssen Pharmaceutical Companies, Johnson & Johnson

  • Timofey Nizhegorodtsev
    Timofey Nizhegorodtsev

    Head, Department for Control of Social Sphere and Trade, Federal Antimonopoly Service of the Russian Federation

  • Elena Razumeeva
    Elena Razumeeva

    Medical Director, A.S. Khlustin Kaluga City Hospital No. 4

  • Iskra Reic
    Iskra Reic

    Vice-President, Russia and Eurasia, CEO, AstraZeneca Russia

  • Andrian Ruigis
    Andrian Ruigis

    Vice-President, Head, Eastern Europe, Middle East, Africa, Russia and the CIS, MSD

  • Anna Yarvits
    Anna Yarvits

    Senior Vice-President, General Manager, Teva Russia & CIS

  • Jeffrey Kemprecos
    Jeffrey Kemprecos

    Executive Director, Emerging Markets Public Policy MSD